A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson's Disease

Protocol No
NEURO-ITI-214-202-LENRISPODUN
Staff Member
Ryan Brennan
Phase
II
Summary

This project is being done to test the effectiveness of lenrispodun to reduce involuntary muscle movements in participants with Parkinson's disease as well as assess the safety of the drug.
Objective
Lenrispodun Adjunctive Therapy in Parkinsons Disease
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Brain, Spinal Cord, and Nervous System, Parkinson's and Movement Disorders
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT05766813